HomeNewsNeuroscience

  • Alder stock suffers after CEO exits months before major drug filing in Migraine

    • March 22, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • EHP-101 shows potential for Remyelination & Disease Modification in MS

    • March 22, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Acute Migraine treatment ZYDIS® ODT enrolls first patient in Ph 3 clinical trial

    • March 21, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • MS patients might suffer from poor perceptions of smell, claims a latest study

    • March 21, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Stem cell transplant offers promise as MS treatment as per latest trial results

    • March 20, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • FDA assisting in withdrawal of Zinbryta (daclizumab) from the market

    • March 20, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more